Antithrombotic prophylaxis
Showing 1 - 25 of 3,044
Prevention of Venous Thromboembolism Trial in Italy (Rivaroxaban, Placebo)
Completed
- Prevention of Venous Thromboembolism
- Rivaroxaban
- Placebo
-
Pozzuoli, Napoli, Italy
- +16 more
Mar 10, 2022
Vasopressors on Anti-Xa Activity in Critically Ill Patients
Recruiting
- Critical Illness
- Thrombosis
- Serum anti-Xa activity
-
Gdańsk, PolandMedical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023
Real-World Mapping Antithrombotic Regimens in MM Patients on
Not yet recruiting
- Multiple Myeloma
- Diagnosis
- (no location specified)
Aug 31, 2023
Atrial Fibrillation, Left Atrial Appendage Occlusion, Silent Cerebral Embolism Trial in Nanjing (aspirin and clopidogrel,
Recruiting
- Atrial Fibrillation
- +2 more
- aspirin and clopidogrel
- Rivaroxaban
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jan 3, 2023
Hallux Valgus, Orthopedic Disorder Trial in Lugano (Partial weight-bearing (10 - 15kg), Complete weight-bearing)
Not yet recruiting
- Hallux Valgus
- Orthopedic Disorder
- Partial weight-bearing (10 - 15kg)
- Complete weight-bearing
-
Lugano, SwitzerlandEOC
Sep 6, 2022
Edema Leg Trial in Pavia (PC Pneumatic compression, AE Antithromboembolic exercises)
Enrolling by invitation
- Edema Leg
- PC Pneumatic compression
- AE Antithromboembolic exercises
-
Pavia, ItalyIstituto di Cura Città di Pavia
May 16, 2022
Colorectal Cancer Metastatic, Thromboembolism Trial in Spain (Tinzaparin)
Not yet recruiting
- Colorectal Cancer Metastatic
- Thromboembolism
-
Santiago De Compostela, A Coruña, Spain
- +32 more
Nov 23, 2022
Incidence and Predictors of Bleeding During and Following ERCP
Recruiting
- Bleeding UGI (During or Post-ERCP)
-
Calgary, Alberta, CanadaPeter Lougheed Center
Jun 26, 2023
Ileostomy - Stoma, Ileus, Rectal Cancer Trial in Leon (Ileostomy stimulation)
Recruiting
- Ileostomy - Stoma
- +3 more
- Ileostomy stimulation
-
Leon, SpainJorge Arredondo
Mar 21, 2022
Septic Shock, Critical Illness Trial in Damanhur Shubra (Heparin Infusion, subcutaneous heparin)
Completed
- Septic Shock
- Critical Illness
- Heparin Infusion
- subcutaneous heparin
-
Damanhūr Shubrā, Egyptamira Bisher kassem
Dec 18, 2022
Venous Thromboembolism in Hematologic Malignancy and
Active, not recruiting
- Thrombosis, Venous
- +4 more
-
Toronto, Ontario, CanadaFederico Carini
Nov 21, 2022
Venous Thromboembolism, Arthroplasty Trial in Chiayi City (Rivaroxaban 10 MG)
Recruiting
- Venous Thromboembolism
- Arthroplasty
- Rivaroxaban 10 MG
-
Chiayi City, TaiwanDitmanson Medical Foundation Chiayi Christian Hospital
Dec 20, 2022
Gynecologic Disease Trial in Geneva ("FAST TRACK" protocol)
Completed
- Gynecologic Disease
- "FAST TRACK" protocol
-
Geneva, Switzerland
- +1 more
Apr 9, 2021
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Incisional Hernia Trial in Konya (primary abdominal closure, abdominal closure with prophylactic mesh)
Completed
- Incisional Hernia
- primary abdominal closure
- abdominal closure with prophylactic mesh
-
Konya, TurkeyHealth Science University Konya City Hospital General Surgery De
Aug 16, 2022
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023
Enoxaparin in Morbidly Obese Adolescents During Bariatric
Completed
- Obesity
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 16, 2022
Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)
Recruiting
- Intracranial Hemorrhages
- Atrial Fibrillation
- Edoxaban
- Non-anticoagulant medical therapy
-
Elk Grove Village, Illinois
- +152 more
Jan 23, 2023
Cancer, Rivaroxaban, Venous Thromboembolism Trial in Santo André (Rivaroxaban, Enoxaparin)
Recruiting
- Cancer
- +3 more
-
Santo André, São Paulo, BrazilScience Valley Research Institute
Aug 3, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Prescribe Antithrombotic Therapy in Older People With Atrial
Recruiting
- Atrial Fibrillation
- Standard of care, with intervention of the multidisciplinary team
-
Paris, FranceUnité de gériatrie aiguë, hôpital Pitié-Salpêtrière (Pr Marc Ver
Oct 31, 2022
Direct Oral AntiCoagulants and Ticagrelor Study II
Not yet recruiting
- Novel Oral Anticoagulants
- +11 more
- Detection of genotype and RNA profile in platelet and white blood cell
- +2 more
-
Hefei, Anhui, China
- +5 more
Mar 1, 2023
Prevention of Venous Thromboembolism Trial in Italy (Application of Padua and IMPROVE Bleeding scores)
Unknown status
- Prevention of Venous Thromboembolism
- Application of Padua and IMPROVE Bleeding scores
-
Casale Monferrato, Alessandria, Italy
- +34 more
Feb 10, 2020
Anti-thrombosis on Cerebral Microbleeds and Intracranial
Recruiting
- Ischemic Stroke
- SWI sequence
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Oct 9, 2022
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO
Completed
- COVID-19
- Hypercoagulability
- Low Molecular Weight Heparin
-
Padova, ItalyGiuseppe Camporese
Mar 17, 2021